BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15140602)

  • 1. The spectrum of antineuronal autoantibodies in a series of neurological patients.
    Vianello M; Vitaliani R; Pezzani R; Nicolao P; Betterle C; Keir G; Thompson EJ; Tavolato B; Scaravilli F; Giometto B
    J Neurol Sci; 2004 May; 220(1-2):29-36. PubMed ID: 15140602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
    Dropcho EJ; King PH
    Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
    Mygland A
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal fixation for the detection of anti-neuronal antibody by immunohistochemistry in the paraneoplastic syndrome].
    Kanazawa N; Tomiyasu K; Ito H; Irie S; Saito T; Kowa H
    Rinsho Byori; 1996 Jul; 44(7):640-6. PubMed ID: 8741494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
    Dalmau J; Porta-Etessam J
    Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subacute neuropathy, multiple cancers, and Gougerot-Sjögren syndrome: contribution of anti-Hu antibody].
    Auf G; Benyahia B; Orcel B; Beigelman C; Delattre JY
    Rev Neurol (Paris); 2001 Feb; 157(2):219-21. PubMed ID: 11283468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoimmunity and paraneoplastic neurologic syndromes].
    Delattre JY; Davila L; Vega F; Poisson M
    Rev Neurol (Paris); 1991; 147(8-9):549-56. PubMed ID: 1962063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticerebellar antibodies--anti-Hu and anti-Yo--in the diagnosis of paraneoplastic neurologic syndromes].
    Grisold W; Drlicek M; Liszka U
    Nervenarzt; 1991 Oct; 62(10):609-14. PubMed ID: 1749452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-neuronal antibodies and central nervous system diseases: contribution to diagnosis and pathophysiology].
    Antoine JC; Honnorat J
    Rev Neurol (Paris); 2000 Jan; 156(1):23-33. PubMed ID: 10693255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease.
    King PH; Redden D; Palmgren JS; Nabors LB; Lennon VA
    J Autoimmun; 1999 Dec; 13(4):435-43. PubMed ID: 10585760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoantibodies in paraneoplastic polioencephalomyelitis: 8 cases].
    Antoine JC; Honnorat J; Pomier G; Belin MF; Le Petit JC; Michel D
    Rev Neurol (Paris); 1992; 148(10):615-21. PubMed ID: 1295056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pure cerebellar syndrome associated with anti-Hu antibodies].
    Pradat PF; Uchuya M; Fontaine B; Lubetzki C
    Rev Neurol (Paris); 1995 May; 151(5):341-3. PubMed ID: 7481393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Idezuka J; Tsuji S
    Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy.
    Molinuevo JL; Graus F; Serrano C; Reñe R; Guerrero A; Illa I
    Ann Neurol; 1998 Dec; 44(6):976-80. PubMed ID: 9851446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of autoantibodies in neurologic disease.
    Zeballos RS; McPherson RA
    Clin Lab Med; 1992 Mar; 12(1):61-83. PubMed ID: 1563241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-neuronal nuclear antibodies, type 1 and type 2].
    Hirose G
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():522-5. PubMed ID: 20942119
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
    Uchuya M; Graus F; Vega F; Reñé R; Delattre JY
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):388-92. PubMed ID: 8774401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-Hu syndrome: a clinical and immunological study of 7 cases.
    Pieret F; Sindic CJ; Chalon MP; Warny M; Bolyn S; Dehaene I; Gobiet Y; Goka S; Laloux P; Monteyne P; Peeters A; Pierre P; Gillet S; Van den Bergh PY; Windhausen K; Laterre C
    Acta Neurol Belg; 1996 Jun; 96(2):108-16. PubMed ID: 8711983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic and clinical study of paraneoplastic limbic encephalitis].
    Chen Q; Li Q; Qian W; Tang Q; Liu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Dec; 20(6):466-9. PubMed ID: 11717941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.